Compounds for the treatment of neuromuscular disorders
US12168643B2 · kind B2 · utility
0Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 19, 2020 |
| Grant date | Dec 17, 2024 |
| Priority date | — |
| Expiry date | Mar 5, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds of Formula I:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.